FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
March 28, 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
March 28, 2024 08:31 ET
|
ReShape Lifesciences Inc
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the...
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024 08:00 ET
|
PharmAla Biotech
PharmAla recieves Allowance from USPTO for its lead drug candidate, a next-generation MDMA composition paving the way for clinical trials
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate
March 27, 2024 02:30 ET
|
Vidac Pharma Holding PLC
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate London (UK), March 27, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G;...
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
March 26, 2024 19:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...
PyroGenesis Announces Acquisition of Intellectual Property Rights Related to the PUREVAPᵀᴹ Nano Silicon Reactor and Nano-Silicon Development
March 26, 2024 07:00 ET
|
PyroGenesis Canada Inc.
MONTREAL, March 26, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs,...
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
March 21, 2024 21:40 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and...
FuelPositive Files Patent for Green Aqueous Ammonia Production Module and Provides Update on First Farm-Ready System
March 21, 2024 20:04 ET
|
FuelPositive Corp.
FUELPOSITIVE FILES PATENT
FOR GREEN AQUEOUS AMMONIA PRODUCTION MODULE
AND PROVIDES UPDATE ON FIRST FARM-READY SYSTEM
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
March 20, 2024 16:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the U.S. Patent and Trademark...
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
March 20, 2024 10:20 ET
|
PharmAla Biotech
PharmAla Recieves Notice of Allowance of Patent on Novel MDMA-like Molecule with improved safety, therapeutic range